Palisade Bio, Inc. (PALI) 追踪市盈率为负值 -6.5, 表示公司目前在过去十二个月 (TTM) 基础上处于亏损状态。 追踪盈利收益率为 -15.50%.
本页证实的标准:
SharesGrow 综合评分： 33/100 其中 1/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | -126.7 | 3.51 | 235.65 | 164,354.03 | - |
| 2017 | -2,162.3 | 50.02 | 3,978.16 | 130,286.73 | - |
| 2018 | -1,563.3 | 20.89 | 1,272.72 | 29,612.99 | - |
| 2019 | -65.3 | 3.63 | 106.39 | 35,425.23 | - |
| 2020 | -319.3 | -0.28 | -464.27 | 0.00 | - |
| 2021 | -0.5 | 0.00 | 1.64 | 0.00 | - |
| 2022 | -4.8 | 0.05 | 5.50 | 0.00 | - |
| 2023 | -0.3 | -0.01 | 0.36 | 16.14 | - |
| 2024 | -0.2 | 0.00 | 0.31 | 0.00 | - |
| 2025 | -7.8 | 0.08 | 1.01 | 0.00 | - |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $-126.11 | $16.25K | $-21.08M | -129724.2% |
| 2017 | $-71.34 | $260K | $-15.67M | -6025.4% |
| 2018 | $-18.02 | $260K | $-4.93M | -1894.2% |
| 2019 | $-35.18 | $15.39K | $-8.35M | -54254.9% |
| 2020 | $-186.00 | $13.52K | $-10.32M | -76346.2% |
| 2021 | $-145.87 | $0.00 | $-26.62M | - |
| 2022 | $-16.53 | $0.00 | $-14.26M | - |
| 2023 | $-27.01 | $250K | $-12.3M | -4920% |
| 2024 | $-1.69 | $0.00 | $-14.44M | - |
| 2025 | $-0.30 | $0.00 | $-16.78M | - |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $-0.25 | $-0.39 – $-0.08 | $27.87M | $27.87M – $27.87M | 4 |
| 2027 | $-0.30 | $-0.41 – $-0.16 | $47.71M | $47.71M – $47.71M | 6 |
| 2028 | $-0.50 | $-0.94 – $-0.25 | $121.55M | $121.55M – $121.55M | 5 |
| 2029 | $-0.45 | $-0.45 – $-0.45 | $415.33M | $415.33M – $415.33M | 1 |
| 2030 | $-0.38 | $-0.38 – $-0.38 | $1.08B | $1.08B – $1.08B | 1 |
